Figure 8
Analysis of ZNF583 in pan-cancer. (A) The expression levels of ZNF583 in 33 different types of cancer were analyzed. (B) The expression of ZNF583 was compared between tumor and normal tissue across different cancer types. (C) The percentage of mutations and summary of gene alterations of ZNF583 were reported across various cancers. (D) The relationship between ZNF583 mRNA expression and copy number alterations (CNAs) was assessed using cBioPortal. (F) The tumor mutation burden of ZNF583 was analyzed in pan-cancer. (G) The microsatellite instability of ZNF583 was analyzed in pan-cancer. (I) Co-expression analysis was performed to investigate the relationship between ZNF583 and immune checkpoints in pan-cancer. (H) Co-expression analysis was performed to investigate the relationship between ZNF583 and immune cells in pan-cancer. *P < 0.05, **P < 0.01, ***P < 0.001.
